A Pilot Study to Assess Safety and Efficacy of SIR1-365 in Patients With Severe COVID-19
- First Posted Date
- 2020-11-09
- Last Posted Date
- 2022-03-24
- Lead Sponsor
- Sironax USA, Inc.
- Target Recruit Count
- 45
- Registration Number
- NCT04622332
- Locations
- 🇺🇸
Triple O Research Institute, West Palm Beach, Florida, United States
🇺🇸Baptist Medical Center, Jackson, Mississippi, United States
🇲🇽Hospital Universitario "Dr. José Eleuterio González", Monterrey, Nuevo León, Mexico
© Copyright 2025. All Rights Reserved by MedPath